Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 2/2011

01-04-2011

Inpatient Enteral and Parental Nutrition for Patients with Diabetes

Authors: Michael A. Via, Jeffrey I. Mechanick

Published in: Current Diabetes Reports | Issue 2/2011

Login to get access

Abstract

Both glycemic control and adequate nutrition support impact the clinical outcome of hospitalized patients. Providing nutrition to malnourished patients using the enteral or parenteral route may increase the risk of hyperglycemia, especially in patients with diabetes. Hyperglycemia can be managed through the use of enteral tube feeds with reduced carbohydrate content or limiting the carbohydrate concentration in parenteral formulas. Judicious use of insulin or other glucose-lowering medications synchronized with appropriate nutrition support allows for optimal inpatient glycemic control.
Literature
1.
(2008) Economic costs of diabetes in the U.S. In 2007. Diabetes Care 31:596–615.
2.
Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE (2009) American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 15:353–369.PubMedCrossRef
3.
Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus. J Manag Care Pharm 16:264–275.
4.
Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F (2007) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 13 Suppl 1:1–68.PubMed
5.
6.
Moghissi ES (2010) Reexamining the evidence for inpatient glucose control: new recommendations for glycemic targets. Am J Health Syst Pharm 67:S3–8.PubMedCrossRef
7.
Furnary AP, Zerr KJ, Grunkemeier GL, Starr A (1999) Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67:352–360; discussion 360–352.PubMedCrossRef
8.
Investigators TN-SS (2009) Intensive versus Conventional Glucose Control in Critically Ill Patients. New England Journal of Medicine 360:1283–1297.CrossRef
9.
van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367.PubMedCrossRef
10.
Krinsley JS (2008) Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 36:3008–3013.PubMedCrossRef
11.
• McClave SA, Martindale RG, Vanek VW, McCarthy M, Roberts P, Taylor B, Ochoa JB, Napolitano L, Cresci G (2009) Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 33:277–316. This is the American Society of Parenteral and Enteral Nutrition most currently released guidelines for nutritional support in inpatients.PubMedCrossRef
12.
Dvir D, Cohen J, Singer P (2006) Computerized energy balance and complications in critically ill patients: an observational study. Clin Nutr 25:37–44.PubMedCrossRef
13.
Villet S, Chiolero RL, Bollmann MD, Revelly JP, Cayeux RNM, Delarue J, Berger MM (2005) Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr 24:502–509.PubMedCrossRef
14.
Bankhead R, Boullata J, Brantley S, Corkins M, Guenter P, Krenitsky J, Lyman B, Metheny NA, Mueller C, Robbins S, Wessel J (2009) Enteral nutrition practice recommendations. JPEN J Parenter Enteral Nutr 33:122–167.PubMedCrossRef
15.
Standards of medical care in diabetes—2010. Diabetes Care 33 Suppl 1:S11–61.
16.
Sheard NF, Clark NG, Brand-Miller JC, Franz MJ, Pi-Sunyer FX, Mayer-Davis E, Kulkarni K, Geil P (2004) Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the american diabetes association. Diabetes Care 27:2266–2271.PubMedCrossRef
17.
Cereda E, Pedrolli C (2009) Way of delivering food in hospital to improve nutrition. Clin Nutr 28:105; author reply 106.PubMedCrossRef
18.
Kaidar-Person O, Person B, Szomstein S, Rosenthal RJ (2008) Nutritional deficiencies in morbidly obese patients: a new form of malnutrition? Part A: vitamins. Obes Surg 18:870–876.PubMedCrossRef
19.
Mechanick JI, Brett EM (2005) Nutrition and the chronically critically ill patient. Curr Opin Clin Nutr Metab Care 8:33–39.PubMedCrossRef
20.
Lochs H, Allison SP, Meier R, Pirlich M, Kondrup J, Schneider S, van den Berghe G, Pichard C (2006) Introductory to the ESPEN Guidelines on Enteral Nutrition: Terminology, definitions and general topics. Clin Nutr 25:180–186.PubMedCrossRef
21.
Krishnan JA, Parce PB, Martinez A, Diette GB, Brower RG (2003) Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest 124:297–305.PubMedCrossRef
22.
Robertson L, Waugh N, Robertson A (2007) Protein restriction for diabetic renal disease. Cochrane Database Syst Rev CD002181.
23.
Port AM, Apovian C (2010) Metabolic support of the obese intensive care unit patient: a current perspective. Curr Opin Clin Nutr Metab Care 13:184–191.PubMedCrossRef
24.
Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ (2005) Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care 28:2267–2279.PubMedCrossRef
25.
Kim HS, Paik HY, Lee KU, Lee HK, Min HK (1988) Effects of several simple sugars on serum glucose and serum fructose levels in normal and diabetic subjects. Diabetes Res Clin Pract 4:281–287.PubMedCrossRef
26.
Hofman Z, van Drunen JD, de Later C, Kuipers H (2004) The effect of different nutritional feeds on the postprandial glucose response in healthy volunteers and patients with type II diabetes. Eur J Clin Nutr 58:1553–1556.PubMedCrossRef
27.
Sturmer W, Kramer E, Kasper H, Schrezenmeir J (1994) Favourable glycaemic effects of a new balanced liquid diet for enteral nutrition—Results of a short-term study in 30 type II diabetic patients. Clin Nutr 13:221–227.PubMedCrossRef
28.
Thomas BL, Laine DC, Goetz FC (1988) Glucose and insulin response in diabetic subjects: acute effect of carbohydrate level and the addition of soy polysaccharide in defined-formula diets. Am J Clin Nutr 48:1048–1052.PubMed
29.
Voss AC, Maki KC, Garvey WT, Hustead DS, Alish C, Fix B, Mustad VA (2008) Effect of two carbohydrate-modified tube-feeding formulas on metabolic responses in patients with type 2 diabetes. Nutrition 24:990–997.PubMedCrossRef
30.
Craig LD, Nicholson S, SilVerstone FA, Kennedy RD (1998) Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial. Nutrition 14:529–534.PubMedCrossRef
31.
McCargar LJ, Innis SM, Bowron E, Leichter J, Dawson K, Toth E, Wall K (1998) Effect of enteral nutritional products differing in carbohydrate and fat on indices of carbohydrate and lipid metabolism in patients with NIDDM. Mol Cell Biochem 188:81–89.PubMedCrossRef
32.
Mesejo A, Acosta JA, Ortega C, Vila J, Fernandez M, Ferreres J, Sanchis JC, Lopez F (2003) Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients. Clin Nutr 22:295–305.PubMedCrossRef
33.
Pohl M, Mayr P, Mertl-Roetzer M, Lauster F, Lerch M, Eriksen J, Haslbeck M, Rahlfs VW (2005) Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: a randomised controlled trial. Eur J Clin Nutr 59:1221–1232.PubMedCrossRef
34.
del Carmen Crespillo M, Olveira G, de Adana MS, Rojo-Martinez G, Garcia-Aleman J, Olvera P, Soriguer F, Munoz A (2003) Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes. Clin Nutr 22:483–487.CrossRef
35.
Peters AL, Davidson MB (1992) Effects of various enteral feeding products on postprandial blood glucose response in patients with type I diabetes. JPEN J Parenter Enteral Nutr 16:69–74.PubMedCrossRef
36.
Peters AL, Davidson MB, Isaac RM (1989) Lack of glucose elevation after simulated tube feeding with a low-carbohydrate, high-fat enteral formula in patients with type I diabetes. Am J Med 87:178–182.PubMedCrossRef
37.
Gul A, Rahman MA, Hasnain SN (2009) Influence of fructose concentration on myocardial infarction in senile diabetic and non-diabetic patients. Exp Clin Endocrinol Diabetes 117:605–609.PubMedCrossRef
38.
Tappy L, Le KA, Tran C, Paquot N (2010) Fructose and metabolic diseases: New findings, new questions. Nutrition.
39.
Scurlock C, Raikhelkar J, Mechanick JI (2010) Critique of normoglycemia in intensive care evaluation: survival using glucose algorithm regulation (NICE-SUGAR)—a review of recent literature. Curr Opin Clin Nutr Metab Care 13:211–214.PubMedCrossRef
40.
Via MA, Scurlock C, Adams DH, Weiss AJ, Mechanick JI (2010) An Impaired Postoperative Hyperglycemic Stress Response is Associated with Increased Mortality in Cardiothoracic Surgery Patients. Endocr Pract 16:798–804.PubMedCrossRef
41.
• Ziegler TR (2009) Parenteral nutrition in the critically ill patient. N Engl J Med 361:1088–1097. This is a recent review article describing current state-of-the-art practices for the use of PN based on all available evidence.PubMedCrossRef
42.
Lin LY, Lin HC, Lee PC, Ma WY, Lin HD (2007) Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci 333:261–265.PubMedCrossRef
43.
Pasquel FJ, Spiegelman R, McCauley M, Smiley D, Umpierrez D, Johnson R, Rhee M, Gatcliffe C, Lin E, Umpierrez E, Peng L, Umpierrez GE (2010) Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care 33:739–741.PubMedCrossRef
44.
Mechanick JI (1996) Parenteral nutrition formulation: an integral part of the endocrinologist’s metabolic support consultation service. Endocr Pract 2:197–203.PubMed
45.
Samuel VT, Petersen KF, Shulman GI (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267–2277.PubMedCrossRef
46.
Hoeg LD, Sjoberg KA, Jeppesen J, Jensen TE, Frosig C, Birk JB, Bisiani B, Hiscock N, Pilegaard H, Wojtaszewski JF, Richter EA, Kiens B (2010) Lipid induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling. Diabetes.
47.
Liu Z, Liu J, Jahn LA, Fowler DE, Barrett EJ (2009) Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. J Clin Endocrinol Metab 94:3543–3549.PubMedCrossRef
48.
Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A (1977) Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30:531–538.PubMed
49.
Via M, Scurlock C, Raikhelkar J, Di Luozzo G, Mechanick JI (2008) Chromium infusion reverses extreme insulin resistance in a cardiothoracic ICU patient. Nutr Clin Pract 23:325–328.PubMedCrossRef
Metadata
Title
Inpatient Enteral and Parental Nutrition for Patients with Diabetes
Authors
Michael A. Via
Jeffrey I. Mechanick
Publication date
01-04-2011
Publisher
Current Science Inc.
Published in
Current Diabetes Reports / Issue 2/2011
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-010-0168-5

Other articles of this Issue 2/2011

Current Diabetes Reports 2/2011 Go to the issue

ReviewPaper

Nutrition Therapy and the Management of Obesity and Diabetes: An Update

Clinical Trial Report

What’s Wrong with Too Low? Is Hypoglycemia a Marker or a Cause of CVD and Mortality Risk?

ReviewPaper

Fad Diets in the Treatment of Diabetes

Invited Commentary

Nonsurgical Diabetes Weight Management: Be Prepared for Sustainable and Practical Interventions

ReviewPaper

Glycemic Index and Glycemic Load of Carbohydrates in the Diabetes Diet

ReviewPaper

Should the Metabolic Syndrome Patient with Prediabetes Be Offered Pharmacotherapy?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits